Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Forte Biosciences, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +8 vs. Q2 2025
- Shares held
- 10.3M
- +272.3K (+2.7%) vs. Q2 2025
- Total value
- $155.1M
- +$24.6M (+18.9%) vs. Q2 2025
- New holders
- 12
- 14 more added
- Sold out
- 4
- 5 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $432.7M |
| Q1 2026 | 68 | $350.2M |
| Q4 2025 | 59 | $314.5M |
| Q3 2025 | 42 | $155.1M |
| Q2 2025 | 34 | $130.4M |
| Q1 2025 | 30 | $40.4M |
| Q4 2024 | 26 | $97.1M |
| Q3 2024 | 24 | $4.12M |
| Q2 2024 | 34 | $10.2M |
| Q1 2024 | 33 | $13.3M |
| Q4 2023 | 35 | $15.5M |
| Q3 2023 | 31 | $11.1M |
| Q2 2023 | 31 | $3.60M |
| Q1 2023 | 31 | $3.90M |
| Q4 2022 | 34 | $3.80M |
| Q3 2022 | 33 | $2.85M |
| Q2 2022 | 40 | $3.01M |
| Q1 2022 | 52 | $5.68M |
| Q4 2021 | 52 | $11.5M |
| Q3 2021 | 58 | $12.8M |
| Q2 2021 | 75 | $289.4M |
| Q1 2021 | 62 | $273.1M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Forte Biosciences, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 2 | $30 | 0.00% | 00.0% | Unchanged |
| REAP Financial Group, LLC | 3 | $45 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 8 | $120 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 13 | $195 | 0.00% | +1+8.3% | Added |
| Assetmark, Inc | 81 | $1.22K | 0.00% | +81 | New |
| Group One Trading, L.P. | 104 | $1.56K | 0.00% | 00.0% | Unchanged |
| Comerica Bank | 150 | $2.25K | 0.00% | −7−4.5% | Reduced |
| Morgan Stanley | 151 | $2.27K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 162 | $2.43K | 0.00% | +162 | New |
| Private Trust Co NA | 274 | $4.11K | 0.00% | +82+42.7% | Added |
| Steward Partners Investment Advisory, LLC | 553 | $8.29K | 0.00% | +553 | New |
| Barclays PLC | 820 | $12.3K | 0.00% | +820 | New |
| UBS Group AG | 1,560 | $23.4K | 0.00% | +1,559+155,900.0% | Added |
| Bank of America Corp | 3,158 | $47.4K | 0.00% | +3,103+5,641.8% | Added |
| Dimensional Fund Advisors LP | 10,765 | $161.0K | 0.00% | +10,765 | New |
| Royal Bank of Canada | 11,253 | $169.0K | 0.00% | +2,019+21.9% | Added |
| Quest Partners LLC | 12,291 | $184.4K | 0.01% | −4,606−27.3% | Reduced |
| Citadel Advisors LLC | 15,633 | $234.5K | 0.00% | +15,633 | New |
| Renaissance Technologies LLC | 16,200 | $243.0K | 0.00% | +16,200 | New |
| Marshall Wace, LLP | 19,165 | $287.5K | 0.00% | +19,165 | New |
| Northern Trust Corp | 23,285 | $349.3K | 0.00% | +23,285 | New |
| Envestnet Asset Management Inc | 23,347 | $350.2K | 0.00% | +4,491+23.8% | Added |
| State Street Corp | 38,097 | $571.5K | 0.00% | +38,097 | New |
| BlackRock, Inc. | 50,662 | $759.9K | 0.00% | +16,967+50.4% | Added |
| BVF Inc | 65,350 | $980.3K | 0.04% | −522,994−88.9% | Reduced |
| Ameriprise Financial Inc | 69,892 | $1.05M | 0.00% | +69,892 | New |
| Mink Brook Asset Management LLC | 81,312 | $1.22M | 0.82% | +42,419+109.1% | Added |
| Geode Capital Management, LLC | 108,318 | $1.63M | 0.00% | +44,208+69.0% | Added |
| Millennium Management LLC | 119,812 | $1.80M | 0.00% | +47,696+66.1% | Added |
| FMR LLC | 244,400 | $3.67M | 0.00% | +244,400 | New |
| AWM Investment Company, Inc. | 261,821 | $3.93M | 0.37% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 300,000 | $4.50M | 1.02% | −176,443−37.0% | Reduced |
| Woodline Partners LP | 331,987 | $4.98M | 0.02% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 333,333 | $5.00M | 0.01% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 474,309 | $7.11M | 1.69% | −20,800−4.2% | Reduced |
| Cable Car Capital LLC | 500,000 | $7.50M | 3.21% | 00.0% | Unchanged |
| Vanguard Group Inc | 566,741 | $8.50M | 0.00% | +79,822+16.4% | Added |
| Tybourne Capital Management (HK) Ltd | 786,647 | $11.8M | 38.15% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,196,955 | $18.0M | 0.43% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 1,403,842 | $21.0M | 0.01% | +8,990+0.6% | Added |
| Federated Hermes, Inc. | 1,635,380 | $24.5M | 0.04% | +563,147+52.5% | Added |
| Fred Alger Management, LLC | 1,636,030 | $24.5M | 0.10% | +17,381+1.1% | Added |
| Heights Capital Management, Inc | 0 | $0 | 0.00% | −143,033−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −68,192−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −58,637−100.0% | Sold out |
| Garde Capital, Inc. | 0 | $0 | 0.00% | −3,960−100.0% | Sold out |